Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
- 专利权人:
- Inc.;Acorda Therapeutics
- 发明人:
- Thomas C. Wessel,Andrew R. Blight
- 申请号：
- US16705711
- 公开号：
- US20200113882A1
- 申请日:
- 2019.12.06
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Disclosed herein are methods and compositions related to use of aminopyridines, such as 4-aminopyridine, to improve the neuro-cognitive impairments and related neuro-psychiatric impairments of patients with a demyelinating condition such as MS, traumatic brain injury, cerebral palsy, post-radiation encephalopathy.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH DEMYELINATING AND OTHER NERVOUS SYSTEM CONDITIONS
- Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
- Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
- USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH DEMYELINATING AND OTHER NERVOUS SYSTEM CONDITIONS
- Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients With Demyelinating and Other Nervous System Conditions
